Lipoprotein (a) and risk of ischemic stroke in young adults

Journal of the Neurological Sciences

Volumn 252, Issue 1, 2007, Pages 39-44

  Rigal, M ^a   Ruidavets, J B ^b   Viguier, A ^a   Petit, R ^a   Perret, B ^b   Ferrieres, J ^b   Larrue, V ^a  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

Author keywords

Ischemic stroke; Lipoproteins; Risk factors; Young adults

Indexed keywords

LIPOPROTEIN A;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; LIPOPROTEINS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK; SEX FACTORS;

EID: 33845463969     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.10.004     Document Type: Article

References (37)

1. Danesh J., Collins R., and Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 102 10 (2000) 1082-1085
2. Sharrett A.R., Ballantyne C.M., Cody S.A., Heiss G., Sorlie P.D., Catellier D., et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104 10 (2001) 1108-1113
3. Hobbs H.H., and White A.L. Lipoprotein(a): intrigues and insights. Curr Opin Lipidol 10 3 (1999) 225-236
4. Milionis H.J., Winder A.F., and Mikhailidis D.P. Lipoprotein (a) and stroke. J Clin Pathol 53 7 (2000) 487-496
5. Milionis H.J., Filippatos T.D., Loukas T., Bairaktari E.T., Tselepis A.D., and Elisaf M.S. Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals. Atherosclerosis 187 1 (2006) 170-176
6. Sun L., Li Z., Zhang H., Ma A., Liao Y., Wang D., et al. Pentanucleotide TTTTA repeat polymorphism of apolipoprotein(a) gene and plasma lipoprotein(a) are associated with ischemic and hemorrhagic stroke in Chinese: a multicenter case-control study in China. Stroke 34 7 (2003) 1617-1622
7. Nguyen T.T., Ellefson R.D., Hodge D.O., Bailey K.R., Kottke T.E., and Abu-Lebdeh H.S. Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women. Circulation 96 5 (1997) 1390-1397
8. Ariyo A.A., Thach C., and Tracy R. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med 349 22 (2003) 2108-2115
9. Gaw A., Murray H.M., and Brown E.A. Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the prospective study of pravastatin in the elderly at risk (PROSPER). Atherosclerosis 180 2 (2005) 381-388
10. Price J.F., Lee A.J., Rumley A., Lowe G.D., and Fowkes F.G. Lipoprotein (a) and development of intermittent claudication and major cardiovascular events in men and women: the Edinburgh Artery Study. Atherosclerosis 157 1 (2001) 241-249
11. Ridker P.M., Stampfer M.J., and Hennekens C.H. Plasma concentration of lipoprotein(a) and the risk of future stroke. JAMA 273 16 (1995) 1269-1273
12. Jurgens G., and Koltringer P. Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. Neurology 37 3 (1987) 513-515
13. Nagayama M., Shinohara Y., and Nagayama T. Lipoprotein(a) and ischemic cerebrovascular disease in young adults. Stroke 25 1 (1994) 74-78
14. Vaverkova H., Novotny D., Ficker L., Vlachova L., and Chudackova J. Lipoprotein (a): a genetic risk factor for early ischemic cerebrovascular stroke. Vnitr Lek 39 10 (1993) 979-987
15. Peynet J., Beaudeux J.L., Woimant F., Flourie F., Giraudeaux V., Vicaut E., et al. Apolipoprotein(a) size polymorphism in young adults with ischemic stroke. Atherosclerosis 142 1 (1999) 233-239
16. Wityk R.J., Kittner S.J., Jenner J.L., Hebel J.R., Epstein A., Wozniak M.A., et al. Lipoprotein (a) and the risk of ischemic stroke in young women. Atherosclerosis 150 2 (2000) 389-396
17. Strater R., Becker S., von Eckardstein A., Heinecke A., Gutsche S., Junker R., et al. Prospective assessment of risk factors for recurrent stroke during childhood-a 5-year follow-up study. Lancet 360 9345 (2002) 1540-1545
18. Rifai N., Ma J., Sacks F.M., Ridker P.M., Hernandez W.J., et al. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: the Physicians' Health Study. Clin Chem 50 8 (2004) 1364-1371
19. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 1 (1993) 35-41
20. Ruidavets J.B., Ducimetiere P., Arveiler D., Amoyel P., Bingham A., Wagner A., et al. Types of alcoholic beverages and blood lipids in a French population. J Epidemiol Community Health 56 1 (2002) 24-28
21. Jurgens G., Taddei-Peters W.C., Koltringer P., Petek W., Chen Q., Greilberger J., et al. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke 26 10 (1995) 1841-1848
22. Arenillas J.F., Molina C.A., Chacon P., Rovira A., Montaner J., Coscojuela P., et al. High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 63 1 (2004) 27-32
23. Kawamoto R., Oka Y., Tomita H., and Kodama A. Non-HDL cholesterol as a predictor of carotid atherosclerosis in the elderly. J Atheroscler Thromb 12 3 (2005) 143-148
24. Loscalzo J., Weinfeld M., Fless G.M., and Scann A.M. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 10 2 (1990) 240-245
25. Marcovina S.M., and Koschinsky M.L. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside. Curr Opin Lipidol 14 4 (2003) 361-366
26. Etingin O.R., Hajjar D.P., Hajjar K.A., Harpel P.C., and Nachman R.L. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. J Biol Chem 266 4 (1991) 2459-2465
27. Buechler C., Ullrich H., Ritter M., Porsch-Oezcueruemez M., Lackner K.J., Barlage S., et al. Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes. Blood 97 4 (2001) 981-986
28. Ezratty A., Simon D.I., and Loscalzo J. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation. Biochemistry 32 17 (1993) 4628-4633
29. Rand M.L., Sangrar W., Hancock W.A., Taylor D.M., Marcorina S.M., Packham M.A., et al. Apolipoprotein(a) enhances platelet responses to the thrombin receptor-activating peptide SFLLRN. Arterioscler Thromb Vasc Biol 18 9 (1998) 1393-1399
30. Caplice N.M., Panetta C., Peterson T.E., Kleppe L.S., Mueske C.S., Kostner G.M., et al. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood 98 10 (2001) 2980-2987
31. Marcovina S.M., Albers J.J., Gabel B., Koschinsky M.L., and Gaur V.P. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem 41 2 (1995) 246-255
32. Schulz U.G.R., and Rothwell P.M. Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke 34 8 (2003) 2050-2059
33. Tirschwell D.L., Smith N.L., Heckbert S.R., Lemaitre R.N., Longstreth Jr. W.T., and Psaty B.M. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63 10 (2004) 1868-1875
34. Andreassen A.K., Berg K., and Torsvik H. Changes in Lp(a) lipoprotein and other plasma proteins during acute myocardial infarction. Clin Genet 46 6 (1994) 410-416
35. Kargman D.E., Tuck C., Berglund L., Lin I.F., Mukherjee R.S., Thompson E.V., et al. Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis 139 2 (1998) 391-399
36. Kronenberg F., Trenkwalden E., Dieplinger H., and Utermann G. Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail. Arterioscler Thromb Vasc Biol 16 12 (1996) 1568-1572
37. Simo J.M., Camps J., Vilella E., Gomez F., Paul A., and Joven J. Instability of lipoprotein(a) in plasma stored at - 70 degrees C: effects of concentration, apolipoprotein(a) genotype, and donor cardiovascular disease. Clin Chem 47 9 (2001) 1673-1678